Medicine
Xeomin 50 units powder for injection
Xeomin 50 units powder for injection is a prescription medicine containing Botulinum toxin type a for intramuscular use, marketed by Merz North, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Refrigeration of unopened vials is not required. Store unopened vials of…
Key facts
- Active ingredient (INN)
- Botulinum toxin type a
- Brand
- Xeomin
- Strength
- 50 units
- Dosage form
- Powder for injection
- Route
- Intramuscular
- Packs
- 1 vial and 1 more
- Marketing authorisation holder
- Merz North
- Manufacturers
- Merz NorthMerz Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Refrigeration of unopened vials is not required. Store unopened vials of XEOMIN at or below 25°C (77°F). Reconstituted XEOMIN may be stored in a refrigerator at 2°C to 8°C (36°F to 46°F) for up to 24 hours until time of use.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 September 2010
- Identifiers
- RxCUI 1009456, 1009459, 1732157 +3DailyMed set ID 3f35d6e0-3450-4abc-a0da-cc7b277e7c6e, ccdc3aae-6e2d-4cd0-a51c-8375bfee9458NDC 46783-161, 0259-1605, 0259-4150 +1Application BLA125360
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-use in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-use | 46783-161-01 | Merz North | 1 August 2011 |
| 1 vial, single-use in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-use | 46783-165-01 | Merz North | 1 August 2011 |
| 1 vial, single-use in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-use | 0259-1605-01 | Merz Pharmaceuticals | 1 September 2010 |
| 1 vial, single-use in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-use | 0259-4150-01 | Merz Pharmaceuticals | 1 September 2010 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Botulinum toxin type a 50 units powder for injection.
Other strengths and forms of Botulinum toxin type a
Clinical summary
Botulinum toxin type a is an acetylcholine release inhibitor indicated for temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/ or procerus muscle activity in adult patients. MedsAcross supplies Botulinum toxin type a for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Botulinum toxin type aFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- DAXXIFY prescribing information (Revance Therapeutics) · U.S. National Library of Medicine, DailyMed
Need Xeomin 50 units powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.